Alexandria Co. For Pharmaceuticals & Chemical Industries (EGX:AXPH)

Egypt flag Egypt · Delayed Price · Currency is EGP
1,177.97
+11.75 (1.01%)
At close: May 13, 2026
Market Cap5.89B +178.2%
Revenue (ttm)3.02B +29.3%
Net Income494.04M +61.5%
EPS98.81 +61.5%
Shares Out5.00M
PE Ratio11.92
Forward PEn/a
Dividend62.95 (5.34%)
Ex-Dividend DateNov 4, 2025
Volume7,341
Average Volume6,186
Open1,166.22
Previous Close1,166.22
Day's Range1,160.02 - 1,230.00
52-Week Range400.02 - 1,239.00
Betan/a
RSI78.44
Earnings DateMay 21, 2026

About EGX:AXPH

Alexandria Co. For Pharmaceuticals & Chemical Industries operates as a pharmaceutical company in Egypt. The company manufactures, markets, and distributes branded generics of human and animal health products. It also provides human products, such as tablets, syrups, suppositories, drops, ampoule, and crème; medical appliances; and Veterinary Products. In addition, the company offers antibiotics and anesthetics, ophthalmic, cardiovascular, gastrointestinal, genitourinary, and respiratory drugs. Alexandria Co. For Pharmaceuticals & Chemical Indus... [Read more]

Founded 1962
Country Egypt
Stock Exchange Egyptian Stock Exchange
Ticker Symbol AXPH
Full Company Profile

Financial Performance

In fiscal year 2025, EGX:AXPH's revenue was 2.75 billion, an increase of 55.56% compared to the previous year's 1.77 billion. Earnings were 391.17 million, an increase of 80.53%.

Financial Statements